Introduction to the Compendium
Much has been published over the years on the enzymology, genetics, and metabolic role of the enzyme phosphoenolpyruvate carboxykinase (GTP) (PEPCK 2 ; EC 4.1.1.32), and much of it has been in the Journal of Biological Chemistry. It is thus not an accident that the Journal is again focusing on this important enzyme in a Compendium that includes the original article by Utter and Kurahashi describing the enzyme, which was published in the Journal of Biological Chemistry in 1954 (1) , as well as a selected series of ten articles that have appeared in the Journal over the past decade. The decision to limit our selection to more recent articles on PEPCK is meant to underline the continued interest in the metabolism and genetics of this enzyme despite the long history of research on its function. The Compendium also features articles in a Minireview series that was published recently in the Journal of Biological Chemistry. Together, they form a primer on our current understanding of the regulation of transcription of the gene for the cytosolic form of PEPCK, the functional insights gained from the recent structural analysis of the enzyme, and the evolving story of its metabolic role in vertebrates.
Historical Background on the Discovery of PEPCK
It is now more than 55 years since the mitochondrial form of PEPCK from chicken liver was first reported by Utter and colleagues in a series of three articles that appeared consecutively in the same issue of the Journal of Biological Chemistry (1) (2) (3) . A co-author of one of the articles in this series is Irwin A. Rose, who later received the Noble Prize for his pioneering research on ubiquitination.
The original literature surrounding the discovery of PEPCK makes interesting reading. In 1935, Harland Wood and Chester Werkman reported that non-photosynthetic, heterotropic bacteria could fix carbon dioxide (4) . They subsequently proposed that pyruvate was carboxylated to form oxalacetate and then converted to succinate in the citric acid cycle; the reaction that fixed carbon dioxide was termed the "Wood-Werkman reaction." The interest in this reaction was greatly stimulated by the discovery that pigeon liver extracts also fixed 13 C-labeled carbon dioxide, synthesizing citric acid cycle intermediates such as succinate and ␣-ketoglutarate (5, 6). There were several possibilities to explain the enzymatic basis for the Wood-Werkman reaction; for example, it was proposed that the conversion of pyruvate to malate by NADP-malate dehydrogenase (malic enzyme) could account for the incorporation of labeled carbon dioxide into malate or, alternatively, by a poorly characterized enzyme, then called oxalacetate carboxylase (7) . This hypothesis was tested by Utter in a study published in 1951 in the Journal of Biological Chemistry (8) , in which he demonstrated that malic enzyme was not responsible for the formation of oxalacetate; this reaction was catalyzed by an enzyme that converted pyruvate, or a related compound, to oxalacetate directly. This finding paved the way for the discovery of the enzyme that is the feature of this Compendium, then termed oxalacetate carboxylase. Utter, Kurahashi, and Rose (3) ultimately demonstrated that the reaction involved phosphoenolpyruvate (PEP) and required IDP (not ADP) as a nucleotide phosphate acceptor. The name of the enzyme was subsequently changed to phosphoenolpyruvate carboxykinase. It is interesting that Utter and Kurahashi (1) initially isolated the mitochondrial isoform of PEPCK (PEPCK-M) from chicken liver. Ironically, this isoform of PEPCK has not been studied in the detail enjoyed by its brother in catalysis, the cytosolic isoform (PEPCK-C); the possible reasons for this will be explored in detail subsequently in this Compendium. In 1961, Utter and Keech (9, 10) reported that pyruvate was carboxylated by a mitochondrial enzyme, pyruvate carboxylase, which had acetyl-CoA as a positive allosteric regulator. With these discoveries, the enzymatic basis of the Wood-Werkman reaction was established; pyruvate is carboxylated to oxalacetate by pyruvate carboxylase (carbon dioxide fixation), which is then converted by PEPCK to PEP. These findings also explained the labeling pattern of [ 14 C]carbon dioxide in the glucose synthesized by mammalian liver. The first article in this Compendium is the first of the original series of articles by Utter and colleagues published in the Journal of Biological Chemistry (1); also included is a photo of Utter and Kurahashi, which was taken in 1955 ( Fig. 1 ). An eyewitness account of the discovery of PEPCK can be found in a 1986 article on this subject by Kiyoshi Kurahashi (11) .
Prospective on the Metabolic Role of PEPCK
Since the discovery of PEPCK in 1953, our understanding of the properties and biological role of this enzyme has increased greatly. We now know, for example, that there are two forms of the enzyme, PEPCK-M and PEPCK-C (12), and rather than being involved exclusively in gluconeogenesis, the enzyme has a broader metabolic function in the cataplerosis of citric acid cycle intermediates (removal of citric acid cycle anions), which is required for gluconeogenesis and glyceroneogenesis (13) . Only the metabolic role of PEPCK-C, the transcription of which is acutely regulated by diet and hormones, has been studied in any detail (14) . This is especially ironic because the genes for both isoforms are found in all eukaryotic species studied to date, and most species have considerable PEPCK-M activity in their tissues. Despite this, PEPCK-C has become a virtual marker for hepatic gluconeogenesis, and the level of its gene transcription in the liver is considered an important indicator in the evaluation of type 2 diabetes. The rationale often used is that an elevation in the level of hepatic mRNA for PEPCK-C signifies an increased rate of gluconeogenesis. This may well be true for the rat and mouse, species that have 90% PEPCK-C in their livers, but in human liver, 50% of the activity is PEPCK-M, which is not induced by the same factors that alter the activity of PEPCK-C (15). This equal distribution of the PEPCK isoforms in the liver is not restricted to humans; most mammalian species have the same relative amounts of the two isoforms of PEPCK (16) . The biology of PEPCK-M has been so poorly studied that it is not even clear if the overall activity of this enzyme can be induced by any of the factors that are known to alter the rate of hepatic gluconeogenesis. The fact that the gene for PEPCK-M is conserved throughout all eukaryotes studied to date attests to the biological importance of the enzyme, but its role in metabolism continues to be largely ignored. It is a casualty of what may be described as the "tyranny of species." As more and more data become available about a given species, the more that species becomes a standard for further study. The case of the mouse is a perfect example. It has become the standard for all metabolic studies, not because it is the ideal animal model for metabolic analysis, but rather because it can be genetically manipulated and the metabolic implications determined. An enormous amount of very valuable metabolic information has been generated over the past 25 years using the techniques of mouse genetics combined with metabolic analysis. Sadly, PEPCK-M represents only 5-10% of the total activity of PEPCK in mouse liver, so deleting the gene in that tissue is unlikely to have a relevant metabolic impact. For example, when PEPCK-C was ablated in the liver, the relatively low activity of PEPCK-M was not sufficient to maintain gluconeogenesis in that tissue (17) . Thus, despite the fact that PEPCK-M was the first isoform of the enzyme identified 55 years ago, its biological function remains to be fully established.
Since its discovery, the function of PEPCK has been linked virtually exclusively to gluconeogenesis despite the fact that the enzyme is present in many tissues that do not make glucose, such as brown and white adipose tissue, the colon, skeletal muscle, the brain, and many others (18) . Several alternative pathways have been suggested to explain the function of PEPCK in these tissues. One such pathway is glyceroneogenesis, which is critical for the generation of glycerideglycerol to support the synthesis of triglyceride in a variety of mammalian tissues (19) . However, it is most likely that the major function of PEPCK in all tissues is cataplerosis; this is a far broader concept upon which to base our understanding of the action of the enzyme. Cataplerosis is an important metabolic process because it is linked to citric acid cycle function and is thus central to energy metabolism (13) . The citric acid cycle is the site of entry of the carbon skeletons of amino acids. However, the cycle does not oxidize these carbon skeletons completely to carbon dioxide, so the entry of amino acid carbon into the cycle must be accompanied by its removal or intermediates will accumulate in the mitochondria. In a broad sense, by converting the citric acid cycle anion oxalacetate to PEP, PEPCK ultimately provides carbon for a number of downstream processes; these include gluconeogenesis and glyceroneogenesis. Equally important, cataplerosis via PEPCK is a pathway for the generation of energy for the carbon skeletons of amino acids (13) because the PEP produced from oxalacetate can be converted to pyruvate via pyruvate kinase and then enter the citric acid cycle as acetyl-CoA (20) . A Journal of Biological Chemistry Minireview by Owen et al. (13) , which focuses on both cataplerosis and anaplerosis, provides an introduction to the importance of cataplerosis in metabolism (13) .
An excellent example of the key role of PEPCK in cataplerosis is found in the article by Stark et al. (21) , who found that PEPCK-M is present in mitochondria from islet cells from both the mouse and rat. There are several very novel aspects of this work. This is the first report that any isoform of PEPCK is present in islets (there is no detectable PEPCK-C in this tissue) and the first indication that PEPCK-M plays a role in the metabolism of rodents and suggests that PEPCK-M may be active in tissues of rodents that have not as yet been assessed. The authors proposed that PEPCK-M is involved in the cataplerotic recycling of citric acid cycle anions that occurs during the glucose-stimulated release of insulin from pancreatic ␤-cells. PEPCK-M recycles the GTP generated in the citric acid cycle by succinyl-CoA synthase back to GDP to ensure continued citric acid cycle function in support of insulin secretion. By this proposal, the anaplerotic formation of oxalacetate by pyruvate carboxylase is coupled to the cataplerotic removal of this metabolite from the citric acid cycle as PEP. In rat islets, Ͼ40% of the PEP comes from this pathway, which is stimulated by Ͼ3-fold by glucose. An important result of this cycling of carbon is the generation of GDP and continued citric acid cycle flux. The overall process is coupled to insulin secretion by ␤-cells. This concept is supported by the observation that ablating PEPCK-M completely inhibited glucosestimulated insulin secretion.
The proposal that PEPCK regenerates mitochondrial GDP as part of an anaplerotic/cataplerotic cycle is not novel. In 1975, Hahn and Novak (22) suggested a similar role for PEPCK-C in brown adipose tissue; when expressed on a protein basis, the enzyme is more active in brown adipose tissue than in any tissue evaluated to date. In brown adipose tissue, the oxidation of fatty acids is critical to support non-shivering thermogenesis as part of the mechanism involved in the uncoupling of respiration from ATP synthesis in that tissue to generate heat. Hahn and Novak (22) proposed a cycle in which pyruvate is carboxylated to oxalacetate in the mitochondria, and the oxalacetate is reduced to malate by NAD-malate dehydrogenase, which is then transported to the cytosol, where it is oxidized to oxalacetate by the cytosolic form of NAD-malate dehydrogenase. PEPCK-C decarboxylates oxalacetate to PEP, and pyruvate kinase converts PEP to pyruvate, completing the cycle. Because the pathway is essentially a futile cycle in brown adipose tissue, it would generate heat as well as convert the GTP generated by succinyl-CoA synthase back to GDP. This is a variant of the role of PEPCK-M in the ␤-cell of the pancreas, which was proposed by Stark et al. (21) .
The role of PEPCK-C in cataplerosis was explored in detail by Burgess et al. (23) using mice in which the gene for PEPCK-C had been deleted specifically in the liver (24) . This study demonstrated that the loss of hepatic PEPCK-C (the gene is expressed normally in the kidney cortex) results in a decreased flux through the citric acid cycle, an accumulation of citric acid cycle intermediates, and an almost total block in hepatic gluconeogenesis and fatty acid oxidation. The authors used an impressive array of techniques in these studies, including metabolic flux measurements of citric acid cycle function, which employ labeled intermediates. The results clearly demonstrate the important cataplerotic role that PEPCK-C plays in the control of citric acid cycle flux and upstream biosynthetic reactions.
PEPCK-C has been shown previously to be present in the skeletal muscle of several rodent species (25, 26) , but its metabolic role in that tissue was not well understood. One suggestion was that PEPCK-C in skeletal muscle was involved in the synthesis of alanine by producing cytosolic PEP, which was then converted to pyruvate by pyruvate kinase and transaminated to alanine (25) . To determine the metabolic function of PEPCK-C in skeletal muscle, Hakimi et al. (27) introduced the structural gene for PEPCK-C into the skeletal muscle of transgenic mice using the ␣-skeletal actin gene promoter; the result was the PEPCK-C mus mouse. This animal has ϳ9 units/g PEPCK-C compared with ϳ0.1 units/g in the skeletal muscle of control mice. The mice have extraordinary endurance; they can run for 5 km at a speed of 20 m/min without stopping compared with control littermates, which run for ϳ0.2 km at that speed before exhaustion. The skeletal muscle of PEPCK-C mus mice has a greatly increased number of mitochondria and accumulates more triglyceride. Overall, however, the mice are lean despite eating almost twice as much as the control mice. Interestingly, PEPCK-C mus mice live far longer than control mice, and the females have an extended reproductive life. As an example, one female PEPCK-C mus mouse, who died recently at 4.5 years of age, gave birth to a normal litter of pups at 35 months of age. 3 The work by Hakimi et al. (27) , included in this Compendium, details many of the characteristics of these unique mice and discusses the possible metabolic role played by PEPCK-C in skeletal muscle that might account for the observed phenotype.
Aspects of the Regulation of PEPCK-C Gene Transcription
The regulation of transcription of the gene for PEPCK-C is among the most thoroughly studied of any gene, and many of the factors that control the level of this enzyme in the major tissues in which it is expressed (i.e. liver, adipose tissue, and kidney cortex) have been identified (see Ref. 14 for a detailed review of this area). The article by Yang et al. (28) reviews several aspects of the control of transcription of the gene for PEPCK-C that would benefit from more intensive research. The current trend in the area has moved away from the analysis of individual promoter function to a more global approach involving co-regulators and co-repressors that interact with specific transcription factors on the gene promoter and alter the rate of expression of the gene. Thus, co-regulators such as peroxisome proliferator-activated receptor ␥ are viewed as "master regulator molecules," which integrate the transcription of a broad variety of genes in response to metabolic signals such as alterations in blood glucose. The detailed analysis of individual genes has largely been relegated to the status of "promoter bashing." This is perhaps inevitable because gene promoters share many of the same regulatory elements and presumably respond in a similar manner to transcriptional regulators. However, making generalizations about global transcriptional control based on the response of the relatively few genes that have been studied in detail is prone to error.
Much has been written on the regulation of PEPCK-C gene transcription and the factors that control its response to hormones and diet (14, 29, 30) . Several articles in this Compendium deal with the hormonal control of PEPCK-C gene transcription and give an excellent example of the type of analysis that has made the PEPCK-C gene promoter so well characterized. Over the years, Daryl Granner and colleagues have made critical contributions to our understanding of the hormonal control of PEPCK-C gene transcription. As an example of this research, two articles are included in this Compendium that detail the mechanisms involved in the control of transcription of the gene by hormones such as insulin and glucocorticoids. The article by Waltner-Law et al. (31) explores the regulatory factors involved in the concerted regulation of PEPCK-C gene transcription by multiple hormones, including insulin and glucocorticoids. The articles stress the point that hormonal regulatory elements work together as regulatory units in the control of transcription of the gene.
Granner and colleagues were the first to note the dominantnegative effect of insulin on the transcription of this gene (32) and continued to study the detailed molecular genetics of insulin action on PEPCK-C in a number of seminal articles published in the Journal of Biological Chemistry; the article by Duong et al. (33) is an example of this research. It presents an analysis of the mechanism of insulin action, focusing on C/EBP␤, a protein known to be important in the control of hepatic PEPCK-C gene transcription. There are several isoforms of C/EBP␤ (LAP (liver enriched transcriptional activator protein)) in the liver, all derived from post-transcriptional processing of its mRNA. One of the isoforms of C/EBP, LIP (liver enriched transcriptional inhibitory protein), is increased by insulin and replaces C/EBP␤ on the PEPCK-C gene promoter, thereby inhibiting transcription of the gene. Because C/EBP␤ interacts with the co-regulatory protein CBP (cAMPresponsive element-binding protein-binding protein), this provides an explanation of how insulin can inhibit PEPCK-C gene transcription even in the presence of cAMP, the primary factor up-regulating PEPCK-C gene transcription during fasting.
Over the years, Lea Reshef and her students and fellows have been instrumental in describing the regulation of PEPCK-C gene transcription. Especially important was the discovery from her laboratory that glucocorticoids stimulate transcription of the gene in the liver but inhibit this process in white adipose tissue (34), She has also pioneered research on the effect of alterations in the pattern of methylation of the gene for PEPCK-C on its transcription in rat liver during development. The significance of this research is documented in detail in this Compendium (35) . The two articles from the Reshef laboratory that are included here are work by Cassuto et al. (36) and work by Olswang et al. (37) , which was published in the Journal in 2003. This study provides a mechanism for glucocorticoid action on PEPCK-C gene transcription in both the liver and adipose tissue. The key finding in the work by Cassuto et al. (36) is the description of a second glucocorticoid regulatory unit, which mirrors the glucocorticoid regulatory unit site first described by Granner and co-workers (38) . The work includes a model for the regulation of PEPCK-C gene transcription by glucocorticoids, which proposes the existence of a "macro palindrome" in the gene promoter and differentiates between the factors that regulate transcription of the gene in the liver and adipose tissue.
Alterations in the expression of the gene for PEPCK-C have been linked to an extended life span in organisms as diverse as yeast (39) and mice (27) . A key factor in the extension of life span has been the sirtuins (40) , a family of proteins that, when activated, catalyze the deacetylation of regulatory proteins (41) . The story comes full circle with the article by Yang et al. (42) , which is included in this Compendium. PEPCK-C gene transcription is inhibited by factors such as resveratrol (a component of red wine), which activates SIR1, thereby deacetylating and inactivating HNF-4␣, a key transcription factor involved in regulating gene transcription. Because PEPCK-C is a major player in gluconeogenesis and hence the rate of hepatic glucose output, the effects of resveratrol and its analogs on transcription of this gene are part of a drug development program aimed at controlling type 2 diabetes in humans (43) .
Least the reader be left with the impression that the only control of the levels of PEPCK-C activity in mammalian tissues involves alterations in gene transcription, an article from the laboratory of Norman Curthoys (44) , a leader in studies of the effect of acid-base status on gene transcription, has been included in this Compendium. PEPCK-C mRNA has a relatively short half-life but is stabilized in the liver by cAMP (45) , which extends its half-life significantly. Specific sequences within the 3Ј-untranslated region of the mRNA interact with proteins that are themselves phosphorylated by protein kinase A (46) . Thus, cAMP not only stimulates PEPCK-C gene transcription but also stabilizes the mRNA against degradation. The article by Hajarnis et al. (44) delineates in detail the binding sites in the 3Ј-untranslated region that are responsible for the effect of cAMP on PEPCK-C mRNA stabilization in the liver.
There are several lines of evidence, some from older literature and others more recent, that support an important role of acetylation of histones and of specific transcription factors in the regulation of PEPCK-C gene transcription (47) (48) (49) (50) (51) . The article in this Compendium by Yang et al. (35) reviews a number of studies that implicate alterations in histone modification as a key factor in the development and regulation of PEPCK-C gene transcription and focuses on the potential insights that may be gained from a critical analysis of the genome-wide sequence of the PEPCK-C gene promoter. As an example, the degree of sequence conservation in eukaryotes of the first 500 bp 5Ј of the start site of gene transcription in the PEPCK-C gene promoter is striking. In addition, the conservation of sequences in the gene promoter provides a new insight into putative regulatory elements that were not recognized previously. There is a hitherto unrecognized Sp1 site within the cAMP regulatory element of the gene promoter, a region that is required for the transcriptional response of the gene to cAMP. How and if Sp1 interacts with members of the C/EBP family of transcription factors that bind at the cAMP regulatory element are not clear. Renal gene transcription requires the HNF-1-binding site (52, 53) , which is present at Ϫ200 to Ϫ164 in the PEPCK-C gene promoter (54) . However, from the genome-wide analysis of promoter sequences, it is apparent that all mammalian species studied have two highly conserved HNF-1-binding sites. The role of these individual sites has not been studied. Finally, there is a common assumption in studies of the control of gene transcription that a gene promoter from one species is an appropriate model for understanding this process in related mammalian species. However, a close analysis of the PEPCK-C gene promoter indicates that the SREBP-1-binding site varies in number and position depending upon the species. This transcription factor stimulates the expression of genes involved in lipid synthesis and was also shown to inhibit transcription of the gene for PEPCK-C in hepatoma cells (55, 56) .
Structure/Function Analysis of PEPCK
The catalytic mechanism of both isoforms of PEPCK has been studied in detail since the enzyme was first isolated. These
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studies resulted in different amino acids being potentially implicated as being involved in catalysis (57) (58) (59) (60) (61) . A giant step toward the development of a unifying mechanism of PEPCK catalysis, invoking potential roles for specific amino acids, came with the determination of the high resolution crystal structures of the enzymes from Escherichia coli in 1996 (62) and PEPCK-C from human liver in 2002 (63) . Building upon the previous body of biochemical data, these structural studies painted a clearer picture of the unique active-site design that allows PEPCK to juxtapose the anionic substrates of the reaction and stabilize the increasing negative charge that develops upon formation of the transition states of the reaction. Complementing the earlier work on PEPCK, more recent structural studies on the mitochondrial and cytosolic isozymes from chicken and rat, respectively (64 -66) , indicate the importance of conformational change in the mechanism of PEPCK catalysis. It is notable, for example, that the active site of both the GTP-and ATP-linked forms of PEPCK is capped by a mobile W-loop lid domain, the closure of which is critical for catalysis (66) . The importance of conformational change at the active site is further illustrated by the necessity for movement of the nucleotide P-loop motif during the catalytic cycle. The dynamic nature of this loop domain provides a mechanistic basis for the longstanding observation that GTP-utilizing isozymes of PEPCK are inactivated by the modification of Cys 288 (57) , which is found to reside in this loop. Inspection of the structural data on PEPCK also suggests an explanation for the nucleotide specificity that is a distinguishing feature between the enzyme from vertebrates, which use GTP as a phosphoryl donor, and the enzyme from yeast and E. coli, which use ATP. The Minireview by Carlson and Holyoak (67) included in this Compendium provides fascinating insight into the reaction mechanism of PEPCK, the details of which have been surprisingly elusive over the years since the discovery of the enzyme.
Final Words
Despite the research over the past 55 years on the metabolism and molecular biology of the two isoforms of PEPCK, much more remains to be done. Many relevant articles on the biochemistry of PEPCK could not be included in this Compendium for lack of space; my apology to all who contributed so much to our understanding of this enzyme. It should be evident to even the casual reader of the articles that are included that there are a number of very large holes in our knowledge of the metabolic role of either isoform of PEPCK. This Compendium has identified some of the gaps in our knowledge. It is my hope that research on this fascinating enzyme continues for the next 55 years. Happy birthday to PEPCK!
